Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Idiopathic pulmonary fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions
Pritha Saha, Priti Talwar
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 9, pp. 2181-2194
Closed Access | Times Cited: 14

Showing 14 citing articles:

Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions
Megh Pravin Vithalkar, Shaili Pradhan, K. Sandra, et al.
Cell Biochemistry and Biophysics (2025)
Open Access | Times Cited: 1
Apigenin as a multifaceted antifibrotic agent: therapeutic potential across organ systems
Xiaoyong Hu, D.J.A.N.D.A.N.T.A.D.U.M. ARTHUR VITHRAN, Zhaoying Yang, et al.
Journal of Agriculture and Food Research (2025), pp. 101816-101816
Open Access
Rosa roxburghii Fermentation Broths Attenuate Bleomycin‐Induced Pulmonary Fibrosis by Activating the Nrf2/HO‐1/NQO1 Signaling Pathway and Modulating Gut Microbiota
Heting Zhou, Xinyue Zheng, Shaolin Huang, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 3
Open Access
The role and clinical significance of myeloperoxidase (MPO) and TNF-α in prognostic evaluation of T-COPD
Erlie Jiang, Yingya Fu, Yalin Wang, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
Nets in fibrosis: Bridging innate immunity and tissue remodeling
Xueni Ma, LI Ji-pin, Muyang Li, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112516-112516
Closed Access | Times Cited: 3
Innovative phytoceutical-based drug delivery in the management of pulmonary fibrosis: A roadmap towards inhaled therapeutics
Shuet Li Wong, Jinfeng Gan, Gabriele De Rubis, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105942-105942
Open Access | Times Cited: 3
Down‐regulation of CYTL1 attenuates bleomycin‐induced pulmonary fibrosis in mice by inhibiting M2 macrophage polarization via the TGF‐β/CCN2 axis
Yan Wang, Chenxi Liu, Yi Xie, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 9
Closed Access | Times Cited: 2
L-arginine mitigates bleomycin-induced pulmonary fibrosis in rats through regulation of HO-1/PPAR-γ/β-catenin axis
Nabil A. Alhakamy, Abdulmohsin J. Alamoudi, Hani Z. Asfour, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111834-111834
Closed Access | Times Cited: 2
Spatially resolved metabolomics visualizes heterogeneous distribution of metabolites in lung tissue and the anti-pulmonary fibrosis effect of Prismatomeris connate extract
Haiyan Jiang, Bowen Zheng, Guang Hu, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 9, pp. 100971-100971
Open Access | Times Cited: 1
Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblastsinto myofibroblasts
Jie Yang, Yuting Huang, Zhiming Cui, et al.
Allergologia et Immunopathologia (2024) Vol. 52, Iss. 4, pp. 15-20
Open Access | Times Cited: 1
The Potential Role of Cigarette Smoke, Elastic Fibers, and Secondary Lung Injury in the Transition of Pulmonary Emphysema to Combined Pulmonary Fibrosis and Emphysema
Jerome Cantor
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11793-11793
Open Access | Times Cited: 1
Development and Evaluation of ABI-171, a New Fluoro-Catechin Derivative, for the Treatment of Idiopathic Pulmonary Fibrosis
Gian Luca Araldi, Yu‐Wen Hwang, Ganesh Raghu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11827-11827
Open Access
Role of Antioxidant Therapy in Respiratory Disease Management
Baby Bhattacharya, Naina Devi, Sanshita, et al.
Antioxidants (2024), pp. 219-255
Open Access
Network Pharmacology and Machine Learning Reveal Salidroside’s Mechanisms in Idiopathic Pulmonary Fibrosis Treatment
Chenchun Ding, Zhenzhen Guo, Quan Liao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 9453-9467
Open Access
JUNB O‐GlcNAcylation‐Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis
Marie‐Therese Bammert, Meshal Ansari, Leoni Haag, et al.
Advanced Science (2024)
Open Access
Page 1

Scroll to top